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During human immunodeficiency virus (HIV) infection, alcohol has been known to induce
inflammation while cannabinoids have been shown to have an anti-inflammatory role.
For instance cannabinoids have been shown to reduce susceptibility to HIV-1 infection
and attenuate HIV replication in macrophages. Recently, we demonstrated that alcohol
induces cannabinoid receptors and regulates cytokine production by monocyte-derived
dendritic cells (MDDC). However, the ability of alcohol and cannabinoids to alter MDDC
function during HIV infection has not been clearly elucidated yet. In order to study the
potential impact of alcohol and cannabinoids on differentiated MDDC infected with HIV,
monocytes were cultured for 7 days with GM-CSF and IL-4, differentiated MDDC were
infected with HIV-1Ba-L and treated with EtOH (0.1 and 0.2%), THC (5 and 10 μM), or
JWH-015 (5 and 10 μM) for 4–7 days. HIV infection of MDDC was confirmed by p24
and Long Terminal Repeats (LTR) estimation. MDDC endocytosis assay and cytokine
array profiles were measured to investigate the effects of HIV and substances of abuse
on MDDC function. Our results show the HIV + EtOH treated MDDC had the highest
levels of p24 production and expression when compared with the HIV positive controls
and the cannabinoid treated cells. Although both cannabinoids, THC and JWH-015 had
lower levels of p24 production and expression, the HIV + JWH-015 treated MDDC had
the lowest levels of p24 when compared to the HIV + THC treated cells. In addition,
MDDC endocytic function and cytokine production were also differentially altered after
alcohol and cannabinoid treatments. Our results show a differential effect of alcohol and
cannabinoids, which may provide insights into the divergent inflammatory role of alcohol
and cannabinoids to modulate MDDC function in the context of HIV infection.
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INTRODUCTION
Since the discovery of the Human Immunodeﬁciency Virus (HIV), the acquired immunodeﬁciency
syndrome (AIDS) epidemic has been consistently associated with substance abuse and in some
cases substance abuse treatment has been proposed as AIDS prevention (Metzger et al., 1998;
Volkow, 2012). Recently, the common problems associated with HIV and substance abuse
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comorbidities have been extensively discussed as demonstrated
by the review of studies in humans and animal models (Chang
et al., 2014; Molina et al., 2015). In the context of alcohol
abuse and HIV comorbidity, a higher prevalence (42%) of
alcohol problems in HIV-infected patients compare to the
prevalence in non-HIV patients has been reported using the
CAGE questionnaire (Samet et al., 2004). In the context of
marijuana abuse and HIV comorbidity, people living with HIV
have been reported to have a higher prevalence of cannabis use
compared to that of the general population (Braitstein et al.,
2001; Furler et al., 2004). For instance, approximately 25% of
HIV/AIDS patients have been reported to use marijuana to
ameliorate nausea, reduce pain, or as an appetite stimulant
(Prentiss et al., 2004); however, the eﬀects of cannabinoids on
immune function of these immunocompromised patients remain
poorly understood.
Overall, alcohol and drugs of abuse may modulate host–
pathogen interactions including immune consequences of HIV
infection. To date, it is well known that both the innate and
adaptive immune systems are a complex network of cells and
cytokines with the primary function of preventing infection.
Although the immune system seems to be very resilient,
there is evidence of the negative eﬀects of environmental
factors such as substances of abuse on immunity (Friedman
et al., 2006). Previous studies using animal models have
demonstrated a correlation between substance-induced
immune dysfunction and greater susceptibility to infections
such as in the case of chronic alcohol consumption and
susceptibility to SIV infection (Kumar et al., 2005; Molina
et al., 2006) or marijuana eﬀects on immune function and
ability to decrease host resistance to infections (Klein et al.,
2003; Cabral and Staab, 2005; Cabral, 2006). Although
substances of abuse have been shown to alter immune
functions in vitro and in animal models, there is a lack of
studies in humans that correlate immunosuppressive eﬀects
with increased incidence of infections, including infection
with HIV as previously reviewed (Cabral, 2006; Molina et al.,
2010a). Therefore, studies on the eﬀects of substances of
abuse such as alcohol and marijuana and their immune-
modulatory mechanisms of action on HIV infection and
disease progression are increasingly on demand since it
is evident that the use of recreational substances such as
alcohol and marijuana is common in this population and the
consequences of substance abuse on HIV infection remain
unclear. As previously reviewed most of the literature has
highlighted the independent role of alcohol or marijuana on
HIV (Chang et al., 2014; Nair and Agudelo, 2014; Molina
et al., 2015; Nair et al., 2015); however, a side by side
comparison of the in vitro eﬀects of alcohol and the role of
cannabinoid compounds such as tetrahydrocannabinol (THC)
and the synthetic cannabinoid, JWH-015, on HIV infection
of monocyte-derived dendritic cells (MDDC) has not been
explored.
In the current study, we report, for the ﬁrst time, the
diﬀerential eﬀects of substances such as alcohol, THC, and JWH-
015, on dendritic cell function after diﬀerentiation and following
HIV infection in vitro. It is hypothesized that alcohol and HIV
can exert their eﬀects on MDDC by altering MDDC functions
and these eﬀects can be inversely regulated by THC and by the
CB2 agonist, JWH-015.
MATERIALS AND METHODS
Differentiation of Monocyte-Derived
Dendritic Cells (MDDC)
For all the in vitro studies, leukopacks were commercially
obtained from the community blood bank (One Blood,
Miami, FL, USA) from at least three diﬀerent blood
donors. MDDC were prepared from peripheral blood
mononuclear cells (PBMC) as previously described by us
(Nair et al., 2005, 2009; Agudelo et al., 2013). Brieﬂy, after
the separation of adherent and non-adherent cells, monocyte
were further puriﬁed using the EasySepTM Human Monocyte
Enrichment Kit (Stemcell Technologies, catalog #19059),
and allowed to diﬀerentiate into MDDC by culturing them
with complete RPMI media containing 100 U/ml of GM-
CSF and 100 U/ml IL-4 (R&D systems, Minneapolis, MN,
USA).
Infection and Treatment of MDDC
After allowing the monocytes to diﬀerentiate for 7 days into
MDDC using cytokines IL-4 and GM-CSF, the MDDCs
were infected and treated. Cells were incubated with
polybrene (2 μl/ml) for 30 min prior to infection with
HIV-1Ba-L (National Institutes of Health AIDS Research
and Reference Reagent Program; catalog no. 510) for 2 h at
a concentration of 20 ng/10 million cells. Cells were then
washed twice to remove unabsorbed virus and treated with
0.1% (∼20 mM) or 0.2% (∼40 mM) EtOH (Sigma–Aldrich,
St. Louis, MO, USA; catalog #E7023), which are equivalent
to the physiological blood alcohol concentrations (BAC) of
50 mg/dL, 100 mg/dL, and 200 mg/dL, respectively, and
are close to the legal limit for driving under intoxication of
0.08% (80 mg/dL). The cannabinoid group was treated with
5–10 μM of 9-THC (Sigma–Aldrich, catalog #T4764) or
5–10 μM of JWH-015 (Tocris Bioscience, Ellisville, MO, USA,
catalog #1341), which are concentrations within the range
of previous reports using monocytes and macrophages
exposed to cannabinoids (Williams et al., 2014; Roth
et al., 2015). After HIV infection and treatments, MDDC
were kept in culture for up to 7 days. Half of media was
replenished every 48 h. Experimental design is provided in
Figure 1.
p24 Secretion by ELISA
Concentrations of HIV-1 p24 antigen in HIV-infected MDDC
culture supernatants were determined according to the
manufacturer’s instructions using commercially available retro-
tek HIV-1 p24 antigen ELISA kit (Cat. #0801111; Zeptometrix,
Buﬀalo, NY, USA). ELISA was performed at days 4 and 7
post-infection and post treatment of MDDC to measure secreted
p24 levels.
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Intracellular p24 Levels by Flow
Cytometry
For intracellular p24 staining, the cells were harvested and
counted; equal amounts of cells (1 × 106) were aliquoted in
12 mm × 75 mm polystyrene falcon tubes, catalog #352058
(BD Biosciences, San Jose, CA, USA), blocked with human
serum (Chemicon International, Temecula, CA, USA), ﬁxed, and
permeabilized with Cytoﬁx/Cytoperm solution (BD Bioscience).
The p24 protein was detected with the anti-p24 FITC-labeled
antibody (KC57-FITC; Beckman Coulter, Indianapolis, IN, USA).
Cells were acquired on an Accuri C6 instrument (BD Accuri,
Ann Arbor, MI, USA) and analyzed with FlowJo software (Tree
Star, INC, Ashland, OR, USA). A total of 10,000 events were
collected for each sample. Cells were gated based on isotype
control, anti-IgG1-FITC (Fisher Scientiﬁc, Pittsburgh, PA, USA,
cat. #1675864). Cells positive for p24 are shown as histogram
overlay with shifted mean ﬂuorescence intensity (MFI) compared
to controls. Percentages of p24 positive cells and MFI were
calculated with FlowJo software.
HIV Long Terminal Repeats (LTR)
Expression by Quantitative Real Time
PCR
Expression levels of HIV LTR were analyzed using real-time,
quantitative PCR. Reverse transcription was performed with
the 2720 Thermal cycler (Applied Biosystems) using aliquots
of total RNA extracted from samples. The cDNA samples
were diluted to 20 ng/ul and gene-speciﬁc primers were used:
forward and reverse LTR HIV-1 primers and Taqman LTR-HIV
(Cat. #VC00021 and VC00023, Sigma–Aldrich). To normalize
the fold changes in gene expression, two internal control
genes were used, GAPDH Taqman primer (Cat. #4331182,
Life technologies) and 18S rRNA (Cat. #4333760F, Applied
Biosystems). Fold changes were calculated based on uninfected
control. All real-time PCR reactions were performed using
the MX3005P detection system (Agilent Technologies) and the
ampliﬁcations were done using the Brilliant II QPCR Master
Mix (Cat. #600804, Agilent Technologies). The thermal cycling
conditions were composed of an initial denaturation step at
95◦C for 10 min, 45 cycles at 95◦C for 30 s and 55◦C for
1 min. The experiments were carried out in duplicates for each
data point. The relative quantiﬁcation in gene expression was
determined using the 2−Ct method (Livak and Schmittgen,
2001).
Endocytosis Assay
AfterMDDCdiﬀerentiation, cells were treated with alcohol, THC
or JWH-015 for 24 h. Then, the cells were cultured with FITC-
dextran (1 mg/ml) in PBS + 1% FBS for 1 h at 37◦C. The assay
was terminated by adding ice-cold PBS. Cell pellets were washed
three times with PBS and the MDDC immediately analyzed for
accumulation of intracellular ﬂuorescence in a Biotek plate reader
(Winooski, VT, USA) at 490 nm excitation and 520 nm emission.
In addition, MDDC infected with HIV and treated with alcohol,
THC, or JWH-015, were also analyzed to assess their endocytic
capacity.
Cytokine Arrays
Supernatants were collected at 7 days post-infection from
MDDC infected with HIV and treated with either EtOH,
THC, or JWH015. The expression of 48 inﬂammatory cytokines
was analyzed as per manufacture recommendations with
the RayBiotech inﬂammation arrays (catalog #AAH-INF-3-8,
RayBiotech, Norcross, GA, USA). Data are expressed as fold
change of cytokines secreted by HIV-infected and treated MDDC
compared to the cytokines secreted by HIV-infected MDDC.
Chemiluminescence signals were detected by a ﬁlm developer
and analyzed by densitometry using Image J software. Data were
further analyzed using the RAYBIO Analysis Tool.
Statistical Analysis
Results are presented as mean ± SEM, and p-values <0.05
are considered signiﬁcant. Data were analyzed using Prism
software (GraphPad Software, La Jolla, CA, USA), and statistical
signiﬁcance was determined by performing unpaired two-tailed
Student’s t-test or ANOVA followed by the Dunnett’s post-test.
All in vitro studies were performed with cells from at least three
diﬀerent donors with multiple replicates (at least two).
RESULTS
Alcohol and Cannabinoids Differentially
Modulate p24 Production by MDDC
To determine if alcohol, THC, and JWH-015 modulate HIV-
1 replication, MDDC were infected by the macrophage tropic
replication competent strain, HIV-1Ba-L, followed by treatment
with alcohol, THC, or JWH-015 using the experimental design
(described in Materials and Methods, Figure 1). Although our
ELISA results have demonstrated an increase in p24 levels over
time after HIV infection (0–7 days), only the alcohol treated
cells showed a signiﬁcant dose dependent increase in p24 levels
at 7 days post-infection (Figure 2A) while both concentrations
FIGURE 1 | Experimental design. Monocytes were allowed to differentiate
into MDDC. MDDC were infected with HIV-1 for 2 h followed by treatment
with alcohol (0.1 and 0.2%), THC (5 and 10 μM) or JWH-015 (5 and 10 μM).
After HIV infection and treatments, MDDC were kept in culture for up to
7 days. Half of media was replenished every 48 h.
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FIGURE 2 | Alcohol and cannabinoids differentially modulate p24 production by MDDC. MDDC were infected with HIV and treated with (A) alcohol, (B) THC,
or (C) JWH-015 for up to 7 days. Supernatants were collected at days 4 and 7 post-infection and analyzed by ELISA to measure p24 levels. Data are expressed as
pg/ml of p24 levels of five individual experiments performed at least in duplicates. Significant p-values are noted on graphs, p ≤ 0.05 is considered significant.
(5 and 10 μM) of THC treatment had no major eﬀect on p24
levels when compared to the HIV infected control (Figure 2B).
Surprisingly, treatment with 10μMof the synthetic cannabinoid,
JWH-015, caused a decrease in p24 levels by 7 days (Figure 2C).
Alcohol and Cannabinoids Differentially
Modulate Intracellular Levels of p24 and
the Percentage of HIV Positive MDDC
Flow cytometry analysis of p24 protein levels revealed an increase
in both mean ﬂuorescent intensity (MFI; Figures 3A,B) and in
the percentage of cells expressing intracellular levels of the viral
p24 core antigen (Figure 4) after 7 days post-infection conﬁrming
the internalization of virus and production of p24 core antigen
by MDDC. In addition, both concentrations of alcohol, 0.1 and
0.2%, (Figures 3C,D) induced more than twofold increase in
MFI when compared to HIV control, while the cannabinoids
caused a reduction in MFI (Figures 3E–H) when compared
to HIV control. Although there were visible diﬀerences in the
modulation of MFI (Figures 3B,D,F,H) and in the percentage of
cells expressing intracellular p24 levels (Figure 4) by alcohol and
cannabinoids (THC and JWH-015), the eﬀects observed were not
statistically signiﬁcant.
HIV-Infection Rate of MDDC is Increased
in the Presence of Alcohol and THC
Assessment of HIV LTR by real-time PCR, conﬁrmed HIV
integration and infectivity of MDDC. Overall, we observed a
dose dependent increase in HIV LTR in alcohol-treated HIV-
infected MDDC compared to the untreated HIV-infected cells;
however, only the higher concentration of alcohol (0.2%) induced
a signiﬁcant expression of LTR (Figure 5A). Although THC
also caused an induction in LTR when compared to control
and alcohol treated cells, it was not statistically signiﬁcant
(Figure 5B). The synthetic cannabinoid, JWH-015 did not aﬀect
LTR expression when compared to HIV control, in contrast, there
was a decrease in LTR after treatment with 10 μM of JWH-015
(Figure 5C).
Alcohol Treatment Induces Higher Levels
of Endocytosis by Uninfected MDDC
When Compare to Control and
Cannabinoid Treated Cells
Receptor mediated endocytosis was measured prior to HIV
infection and after HIV infection by the uptake of FITC-dextran.
Our results show a signiﬁcant increase of FITC-dextran intake by
MDDC that had been treated with alcohol (0.1%), THC (5 μM),
or JWH-015 (5 μM; Figure 6). Although all treatments increased
endocytosis in uninfected cells, THC and JWH-015 treated cells
showed signiﬁcantly lower levels of endocytosis when compared
to alcohol treated MDDC. The overall increase in endocytosis by
the substance abuse treated cells was only observed prior to HIV
infection since after the cells were infected with HIV, there was
an overall decrease in endocytosis with no diﬀerences across the
groups.
Alcohol and Cannabinoids Differentially
Modulate MDDC Cytokine Profiles
During HIV Infection
The production of cytokines was assessed after HIV infection
and stimulation with alcohol, THC or JWH-015. A summary
of the cytokines that were modulated (≥ threefold) during HIV
infection and substance abuse treatment are shown in Figure 7
(A) 0.1% alcohol, (B) 5 μM THC, and (C) 5 μM JWH-015.
Treatment of HIV-infected MDDC with 0.1% alcohol caused
an induction of seven cytokines (G-CSF, IL-3, IL-7, M-CSF,
TGF-β1, s TNF RI, and s TNF RII), while treatment with
5 μM THC induced the levels of ﬁve cytokines (IL-3, IL-7,
M-CSF, TGF-β1, s TNF RI), and treatment with 5 μM JWH-015
upregulated only three cytokines (IL-11, M-CSF, and PDGF-BB).
Cytokine downregulation was also observed across the groups,
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FIGURE 3 | Alcohol and cannabinoids differentially modulate intracellular levels of p24 in MDDC. MDDC were infected with HIV and treated with alcohol,
THC or JWH-015 for up to 7 days prior to assessing intracellular p24 levels by flow cytometry. A representative histogram overlay is shown in this figure (A,C,E,G).
Mean Fluorescence Intensity (MFI) corresponding to histogram overlays were calculated using FlowJo software and are shown in this figure (B,D,F,H). A total of
10,000 events were collected for each sample. Cells were gated based on isotype control. Data are expressed as % of p24 positive cells and MFI of FITC-labeled
p24 and are representative of three individual experiments performed at least in duplicates.
0.1% alcohol treatment downregulated seven cytokines (Eotaxin,
IL-1β, IL-11, IL-16, IL-17, MIG, and PDGF-BB), while 5 μM
THC treatment downregulated six cytokines (Eotaxin, IL-1β,
IL-11, IL-12 p40, MIG, PDGF-BB), and treatment with 5 μM
JWH-015 caused downregulation of two cytokines (Eotaxin and
TGF-β1). Speciﬁc fold diﬀerences between treatments and HIV
control are highlighted in Table 1.
DISCUSSION
Our study supports evidence of a major role of MDDC in
the enhancement of HIV infection and integration in vitro.
Although the MDDC role during HIV infection has been
somehow controversial due to the discrepancy regarding HIV
infection of MDDC and evidence showing that HIV spreads
from virus-containing MDDC (not necessarily productively
infected) to T cells via an infectious synapse (McDonald et al.,
2003; Blanchet et al., 2011), MDDC are professional antigen
presenting cells and they do get productively infected with HIV
as shown by previous reports (Scott-Algara et al., 2008) and
our own current ﬁndings demonstrating an increase in p24
intracellular levels, p24 secretion, and LTR. Despite MDDC
questionable ability to get productively infected with HIV, they
play a major role during HIV-1 trans infection of CD4+ T cells
as previously reviewed (Agudelo et al., 2010; Rinaldo, 2013).
Moreover, there is evidence of the ability of circulating DC
to purge HIV-1 from latency and re-initiate virus replication
in proliferating primary T lymphocytes (van der Sluis et al.,
2013).
To the best of our knowledge, this is the ﬁrst report that
performs a side by side comparison of the in vitro eﬀects
of alcohol and cannabinoids in MDDC infected with HIV.
We analyzed the eﬀects of alcohol, THC, and JWH-015 on
HIV infection and integration by measuring p24 production,
intracellular p24 levels, and LTR. In addition, the immune-
modulatory eﬀects of these substances on MDDC function under
HIV infection were also evaluated as measured by endocytosis
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FIGURE 4 | Alcohol and cannabinoids differentially modulate the
percentage of HIV positive MDDC. MDDC were infected with HIV and
treated with alcohol, THC or JWH-015 for up to 7 days prior to assessing
intracellular p24 levels by flow cytometry. Bar graphs correspond to the
percentage of MDDC positive for p24 antigen. A total of 10,000 events were
collected for each sample. Cells were gated based on isotype control. Data
are expressed as % of p24 positive cells of three individual experiments.
and cytokine production. Our results show in vitro alcohol
treatment of MDDC increased p24 secretion (Figure 2A),
intracellular p24 levels (Figures 3C,D and 4), percentage of
cells expressing p24, and LTR (Figure 5A). Our ﬁndings are
in accordance with previous reports showing alcohol enhances
HIV-1 infection of human monocyte-derived cells; however,
those reports were performed in cord blood monocyte-derived
macrophages (Mastrogiannis et al., 2014) and in bloodmonocyte-
derived macrophages (Wang et al., 2002). Furthermore, alcohol
ingestion has been shown to increase HIV-1 replication in
human PBMC, which may be due to alcohol-induced functional
impairment of various subsets of lymphocytes in the peripheral
blood (Bagasra et al., 1993). In addition, substantial evidence
from animal (Kumar et al., 2005; Molina et al., 2006; Sarkar and
Chang, 2013) and human studies (Míguez-Burbano et al., 2009;
Baum et al., 2010; Molina et al., 2014) has demonstrated that
alcohol has an immune-modulatory eﬀect during HIV disease
progression and has the ability to disrupt HAART (Míguez-
Burbano et al., 2009). More speciﬁc associations between
alcohol consumption and lower levels of CD4 T cells have
been reported among HIV-infected alcoholic patients (Samet
et al., 2007; Baum et al., 2010). However, additional studies
are necessary to elucidate the mechanisms of alcohol-induced
immune-modulation in the context of HIV infection.
In contrast to alcohol results, when the HIV-infected
MDDC were treated with the main psychoactive component
of marijuana, THC, there were no changes in p24 secretion
(Figure 2B). However, there was an evident decrease in p24
intracellular levels (Figures 3E,F) and in the percentage of cells
expressing p24 (Figure 4) implying a reduction in HIV infection.
Surprisingly, when LTR levels were examined, integration seemed
to be elevated since THC acted similar to alcohol by inducing
LTR (Figure 5B) levels; although, the induction had high
variability between samples and was not signiﬁcant. In contrast, a
previous report using THC immediately prior to or continuously
following HIV-1 exposure failed to alter infection (Williams et al.,
2014). However, their study was performed with primary human
monocytes and treatment was performed during diﬀerentiation
of monocytes. Although in diﬀerent cells and under diﬀerent
treatment conditions, some of their ﬁndings (Williams et al.,
2014) are somehow consistent to our results showing that THC
reduced the number of p24 positive cells (Figure 4) with little to
no eﬀect on virus production (Figure 2B). It is relevant to point
FIGURE 5 | HIV-infection rate of MDDC is increased in the presence of alcohol and THC. MDDC were infected with HIV and treated with (A) alcohol,
(B) THC, or (C) JWH-015 for up to 7 days prior to assessment of HIV LTR by real-time PCR. Data are expressed as Transcript Accumulation index (TAI). To normalize
the fold changes in gene expression, two internal control genes were used, GAPDH and 18S rRNA. Fold changes were calculated based on uninfected control. Data
are representative of three individual experiments performed at least in duplicates.
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FIGURE 6 | Alcohol treatment induces higher levels of endocytosis by
uninfected MDDC when compare to control and cannabinoid treated
cells. After MDDC differentiation, cells were treated with alcohol, THC or
JWH-015 for 24 h. In addition, MDDC infected with HIV followed by treatment
with alcohol, THC, or JWH-015 were also analyzed for FITC-Dextran uptake.
Data are expressed as relative fluorescence units (RFU) representing
FITC-Dextran uptake by uninfected (light gray bars) and infected (black bars)
MDDC. Data are representative of three individual experiments performed at
least in duplicates. Significant p-values are noted on graphs, p ≤ 0.05 is
considered significant.
out that in our in vitro ﬁndings, there were no diﬀerences in p24
secretion when we compared THC treated HIV-infected MDDC
with non-treated HIV-infected MDDC. Similarly, animal studies
have shown that simian immunodeﬁciency virus (SIV)-infected
female rhesus macaques exposed to chronic administration of
THC prior to and following SIV infection exhibited no changes in
markers of SIV disease, including viral load (Amedee et al., 2014).
However, there were contrasting eﬀects of chronic THC exposure
in males versus females, with males having lower plasma and CSF
viral loads (Molina et al., 2010b).
In an eﬀort to elucidate the mechanism of THC suppression of
HIV-1 infection, we also performed treatment with CB2 agonist,
JWH-015. HIV-infected MDDC treated with JWH-015 showed a
decrease in p24 secretion by 7 days post-infection (Figure 2C), a
decrease in p24 intracellular levels (Figures 3G,H) and a decrease
in the percentage of p24 positive cells (Figure 4) when compared
with the HIV-infected control or the HIV-infected alcohol treated
cells. We also observed a decrease in LTR levels after treatment
with 10μMJWH-015 when compared with HIV-infected control
and HIV-infected alcohol or cannabinoid treated cells. These
ﬁndings may support a major role of CB2 receptors in the
HIV replication machinery, and these results are in accordance
with previous ﬁndings with macrophages revealing a marked
decrease in HIV-1 LTR activation by the CB2 ligands, JWH133,
GP1a, O-1966 and showing a signiﬁcant decrease in RT activity
when a CB2 agonist was present (Ramirez et al., 2013). Taken
together, these results using MDDC and previous ﬁndings with
macrophages (Ramirez et al., 2013) indicate that CB2 may limit
HIV-1 infection in human monocyte-derived cells. Furthermore,
a similar study with JWH-133, ACEA, and O-1602 indicated
that the ability of THC to reduce macrophage susceptibility to
HIV infection during monocyte diﬀerentiation was mediated
primarily through CB2 (Williams et al., 2014).
FIGURE 7 | Alcohol and cannabinoids differentially modulate MDDC
cytokine profiles during HIV infection. The production of cytokines by
MDDC was assessed after HIV infection and stimulation with alcohol (0.1%),
THC (5 μM) or JWH-015 (5 μM). Supernatants were collected at 7 days
post-infection and used to investigate the expression of 48 inflammatory
cytokines with the RayBiotech inflammation arrays. A summary of the
cytokines that were modulated (≥ threefold) during HIV infection and
substance abuse treatment are shown in this figure (A) 0.1% alcohol, (B)
5 μM THC, and (C) 5 μM JWH-015. Data are expressed as fold change of
cytokines secreted by HIV-infected and treated MDDC compared to the
cytokines secreted by HIV-infected MDDC. Chemiluminescence signals were
analyzed by densitometry using Image J software. Data were further analyzed
using the RAYBIO Analysis Tool.
Besides modulation of HIV infection of MDDC, our results
demonstrate the ability of alcohol and cannabinoids (THC and
JWH-015) to aﬀect DC function as shown by an increase in
endocytosis in uninfected cells and an overall decrease in the
endocytic capacity after HIV infection (Figure 6). These ﬁndings
may be explained by the capacity of immature dendritic cells
to be highly endocytic (Garrett et al., 2000) and the ability
of HIV-1BaL to induce partial maturation of dendritic cells
(Mercier et al., 2013). Therefore, based on our results and
previous literature (Mercier et al., 2013) the observed decrease
in endocytosis after HIV infection and the attenuation of the
substance abuse-induction of endocytosis might be due to
the maturation status of the MDDC. We are the ﬁrst ones
to show an induction of endocytosis by healthy uninfected
Frontiers in Microbiology | www.frontiersin.org 7 December 2015 | Volume 6 | Article 1452
Agudelo et al. Alcohol, Cannabinoids, and HIV Infection
TABLE 1 | Summary of the effects of alcohol and cannabinoids, THC and
JWH-015 on the modulation of cytokine production by HIV-infected
MDDC.
Cytokine EtOH 0.1% THC 5 µM JWH-015 5 µM
EOTAXIN –52.3 –55.2 –15.5
GCSF 3.0 2.8 0.6
ICAM-1 1.5 1.6 1.1
I-309 0.6 1.8 2.0
IL-1β –20.5 –4.0 2.1
IL-3 9.1 6.9 2.3
IL-6sR 2.5 2.6 1.6
IL-7 4.4 5.6 0.1
IL-11 –8.3 –16.2 16.7
IL-12 p40 –1.4 –5.5 1.4
IL-12 p70 0.3 0.0 2.4
IL-16 –4.1 –1.4 1.1
IL-17 –3.1 –1.5 1.5
M-CSF 24.1 37.1 3.1
MIG –3.6 –4.2 1.7
MIP-1α 2.7 2.9 2.0
MIP-1δ 1.1 3.0 1.7
TGF-β1 8.7 3.3 –5.6
TNF-α –0.9 0.5 2.1
TNF-β –2.6 –0.4 2.7
s TNF RI 8.3 4.9 –0.7
s TNF RII 4.1 2.5 0.1
PDGF-BB –64.9 –46.4 10.4
Cytokine array was conducted using supernatants from HIV-infected MDDC treated
with alcohol (0.1%), THC (5 μM), of JWH-015 (5 μM). A summary of cytokines with
more than threefold increase (light gray) or decrease (dark gray) are highlighted in
the table. Data are expressed as fold change of cytokines secreted by HIV-infected
and treated MDDC compared to the cytokines secreted by HIV-infected MDDC.
MDDC treated with alcohol or cannabinoids. Previous literature
in the context of alcohol has demonstrated the ability of
alcohol to modulate endocytosis; however, the reports are in
rat hepatocytes, in which ethanol impaired receptor-mediated
endocytosis (Casey et al., 1989; Tuma et al., 1991). In the
context of cannabinoids, there is evidence demonstrating that
exposure to THC impairs the capacity for receptor-mediated
endocytosis by human dendritic cells (Roth et al., 2015); however,
their immunoregulatory eﬀects on humanMDDCwere observed
at lower THC concentrations (0.5–3.2 μM). Other ﬁndings in
mice, have demonstrated that under certain conditions, THC
enhances HIV antigen-speciﬁc immune responses (Chen et al.,
2015).
In the past, alcohol and cannabinoids have been shown to
alter several aspects of immune function including cytokine
production and lymphocyte phenotype (Friedman et al., 1995,
2003; Szabo, 1999; Klein et al., 2003; Szabo et al., 2004;
Crews et al., 2006; Molina et al., 2010a). According to the
cytokine analysis performed (Figure 7 and Table 1), alcohol and
cannabinoids induced diﬀerential cytokine production by HIV-
infected MDDC and caused a major immune-modulatory eﬀect,
which may exacerbate HIV infection and pathogenesis. When
compared to HIV control, alcohol (0.1%) and THC (5 μM)
treatments had similar eﬀects and induced IL-3, IL-7, M-CSF,
TGF-β1, sTNF RI, and sTNF RII while decreasing IL-1β, IL-
11, IL-12p40, TNFβ, and PDGF-BB. However, the JWH-015
treatments had opposing eﬀects as shown by an increase on
IL-1β, IL-11, IL-12p40, and IL-12 p70, MCSF, MIP1α, TNFα,
TNFβ, and PDGF-BB while reducing only TGF-β1 and sTNF RI.
All three substances, alcohol (–52.3), THC (–55.2) and JWH-
015 (–15.5), remarkably reduced the levels of eotaxin, which
is a chemokine associated with lower susceptibility to infection
in macaques (Promadej-Lanier et al., 2010). Another unique
diﬀerence observed was on the eﬀects on IL-11 production after
alcohol (–8.3), THC (–16.2), and JWH-015 (16.7) treatments.
This is relevant since IL-11 may reduce HIV-1-mediated immune
activation while achieving elimination of virally infected cells
as previously reported (Favors et al., 2012). Lastly, the eﬀects
on PDGF-BB were also diﬀerent between alcohol (–64.9),
THC (–46.4) versus JWH-015 (10.4) treatments. This is relevant
within the HIV ﬁeld since platelet-derived growth factor (PDGF)
is one of the toxic mediators shown to be upregulated in the
brains of macaques with SIV encephalitis and shown to play
a major role in HIV neuro-pathogenesis (Potula et al., 2004;
Bethel-Brown et al., 2011).
Overall, the diﬀerential immune-modulatory eﬀects of
alcohol and cannabinoids could be explained by the diﬀerent
mechanisms of action of these substances since the eﬀects of
marijuana on the immune system have been demonstrated to
be receptor-mediated, occurring directly via speciﬁc receptors
on immune cells (Friedman et al., 2003). For instance, THC
exerts its eﬀects through both CB1 and CB2 receptors (Matsuda
et al., 1990; Munro et al., 1993), while JWH-015 acts as a
CB2 agonist (Huﬀman, 2000). Unlike cannabinoids and other
addictive drugs of abuse, alcohol, does not appear to bind to
a speciﬁc receptor (Peter et al., 2008). In summary alcohol
and cannabinoids have been shown to induce neuro-immune-
modulatory consequences during healthy conditions and during
HIV infection and disease progression as highlighted in several
recent reviews (Chang et al., 2014; Molina et al., 2015; Nair et al.,
2015). Our current ﬁndings were able to highlight a divergent
role of both substances in HIV infection and integration of
human MDDC, and along with future studies, will allow us to
elucidate the immunological consequences of alcohol and/or
cannabinoids on the innate and adaptive immune system of an
immune-compromised host. However, additional studies are
still necessary to elucidate the molecular mechanisms involving
alcohol and/or cannabinoid induced eﬀects in the context of HIV
infection.
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